Phibro Animal Health Corporation · NASDAQ:PAHC
Phibro Animal Health — Q3 FY2020 Earnings Presentation
12 slides from Phibro Animal Health's earnings presentation, May 8, 2020
Slide 1: Phibro Animal Health Corporation Third Quarter Webcast and Conference Call
Phibro Animal Health Corporation Third Quarter – March 31, 2020 U.S. toll-free +1-866-211-3051 Webcast and Conference Call International toll +1-647-689-6616 May 8, 2020 Conference ID: 7169811
Slide 2: Cautionary Statements
Cautionary Statements Forward-Looking Statements This communication contains forward-looking statements that are subject to risks and uncertainties. All statements other than statements of historical or current fact included in this report are forward-looking statements. Forward-looking statements d
Slide 3: GAAP and Non-GAAP Financial Information
GAAP and Non-GAAP Financial Information Reported results are presented in accordance with GAAP Adjusted results are GAAP results adjusted to exclude - Acquisition-related items, including intangible amortization, cost of goods sold, accrued compensation costs, transaction costs and accrued interest
Slide 4: Opening Remarks and Financial Review
Opening Remarks and Financial Review Jack Bendheim Chairman, President, Chief Executive Officer Richard Johnson Chief Financial Officer 4 May 8, 2020 Webcast and Conference Call
Slide 5: Highlights
Highlights Q3 – March 2020 Consolidated Sales growth in the Animal Health business was partially offset by lower average selling prices in For the three months ended Mineral Nutrition and decreased sales in 2020 2019 Change March 31 Performance Products. The increase in Animal (in millions, except p
Slide 6: Selected Line Items
Selected Line Items Q3 – March 2020 Consolidated Adjusted gross profit For the three months ended March 31 2020 2019 Change - Animal Health volume growth in nutritional (in millions, except per share amounts and percentages) specialty products and vaccines were partially offset by lower volumes in M
Slide 7: Animal Health
Animal Health Q3 – March 2020 MFAs and other - Lower demand in China due to ASF and phased Animal Health regulatory change, beginning January 1, 2020 For the three months ended 2020 2019 Change - Increased demand from poultry and cattle customers March 31 in U.S. and Latin America (in millions, exce
Slide 8: Other Segments
Other Segments Q3 – March 2020 For the three months ended March 31 2020 2019 Change Mineral Nutrition (in millions, except percentages) - Sales decreased due to lower average selling Mineral Nutrition prices, partially offset by volume growth Net sales $ 56.2 $ 60.7 $ (4.5) (7)% - Adjusted EBITDA de
Slide 9: Capitalization
Capitalization March 31, 2020 3.5x leverage ratio at March 31, 2020 - $368 million total debt - $105 million LTM Adjusted EBITDA $82 million cash and short-term investments on hand at March 31, 2020 $19 million source of cash before financing for the March 2020 quarter, excluding changes in short-te
Slide 10: Withdrawal of Guidance for our Fiscal Year 2020
Withdrawal of Guidance for our Fiscal Year 2020 Year – June 2020 Due to the COVID-19 pandemic, the animal production industry is facing unprecedented demand disruption and production impacts, including its ability to process animals. Animal producers are rapidly adjusting the amount of animals and m
Slide 11: Q&A Session
Q&A Session 11 May 8, 2020 Webcast and Conference Call
Slide 12: © 2020 Phibro Animal Health Corporation trademark notice
© 2020 Phibro Animal Health Corporation, Teaneck, NJ 07666 Phibro; Phibro logo design; Healthy Animals. Healthy Food. Healthy World.; and any other Phibro brand or brands shown herein are trademarks owned by or licensed to Phibro Animal Health Corporation or its affiliates. Any other trademark that
Phibro Animal Health — Q3 FY2020 Earnings Presentation on 6ix